would CRH ever be sold to rationalize shareholder value?the market cap of this company is not enormous (especially since the stock is depressed) and CRH has a huge untapped market of GI professionals to acquire. there are no competitors. with the proper capital the company could grow exponentially. this was the basis for the run up to $12 - the potential growth story.
it wouldn't shock me if a Private Equity firm or another healthcare company were looking at this. total speculation and you can never time these things, but there is certainly a case. company insiders and institutional shareholders would easily approve this.
something to think about.